Article info
PDFClinical science
Long-term outcomes of intravitreal ranibizumab for neovascular age-related macular degeneration in a well defined region of the UK
- Correspondence to Robert L Johnston, Eye Department, Cheltenham General Hospital, Sandford Road, Cheltenham GL53 7AN, UK; rob.johnston{at}glos.nhs.uk
Citation
Long-term outcomes of intravitreal ranibizumab for neovascular age-related macular degeneration in a well defined region of the UK
Publication history
- Received November 20, 2014
- Revised May 12, 2015
- Accepted June 5, 2015
- First published June 29, 2015.
Online issue publication
March 22, 2016
Article Versions
- Previous version (22 March 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/